Nafamostat mesylate versus low-molecular-weight heparin during continuous renal replacement therapy in critically Ill adults: a single-center retrospective cohort study
- DOI
- 10.1186/s12882-026-05351-9
- Published
- 2026-09-07
- Container
- BMC Nephrology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12882-026-05351-9,
title = {Nafamostat mesylate versus low-molecular-weight heparin during continuous renal replacement therapy in critically Ill adults: a single-center retrospective cohort study},
author = {Xianguo Zeng and Yutong Xiao and Chaoqun Zhang and Yide Li and Yongjun Liu and Liang Luo},
year = {2026},
journal = {BMC Nephrology},
doi = {10.1186/s12882-026-05351-9},
url = {https://doi.org/10.1186/s12882-026-05351-9}
}RIS
TY - JOUR TI - Nafamostat mesylate versus low-molecular-weight heparin during continuous renal replacement therapy in critically Ill adults: a single-center retrospective cohort study AU - Xianguo Zeng AU - Yutong Xiao AU - Chaoqun Zhang AU - Yide Li AU - Yongjun Liu AU - Liang Luo PY - 2026 JO - BMC Nephrology DO - 10.1186/s12882-026-05351-9 UR - https://doi.org/10.1186/s12882-026-05351-9 ER -
APA
Zeng, X., Xiao, Y., Zhang, C., Li, Y., Liu, Y., & Luo, L. (2026). Nafamostat mesylate versus low-molecular-weight heparin during continuous renal replacement therapy in critically Ill adults: a single-center retrospective cohort study. BMC Nephrology. https://doi.org/10.1186/s12882-026-05351-9
Source records
- crossref · retrieved 2026-09-25T19:14:18.895Z